nodes	percent_of_prediction	percent_of_DWPC	metapath
Oseltamivir—SLC22A8—choroid plexus—malignant glioma	0.12	0.425	CbGeAlD
Oseltamivir—NEU1—telencephalon—malignant glioma	0.0316	0.111	CbGeAlD
Oseltamivir—Abnormal behaviour—Temozolomide—malignant glioma	0.0258	0.0494	CcSEcCtD
Oseltamivir—NEU1—medulla oblongata—malignant glioma	0.0248	0.0874	CbGeAlD
Oseltamivir—NEU1—midbrain—malignant glioma	0.0227	0.0799	CbGeAlD
Oseltamivir—NEU1—spinal cord—malignant glioma	0.0221	0.078	CbGeAlD
Oseltamivir—NEU1—cerebellum—malignant glioma	0.0175	0.0618	CbGeAlD
Oseltamivir—Encephalopathy—Carmustine—malignant glioma	0.0155	0.0296	CcSEcCtD
Oseltamivir—NEU1—brain—malignant glioma	0.0142	0.0502	CbGeAlD
Oseltamivir—Hepatotoxicity—Carmustine—malignant glioma	0.0129	0.0246	CcSEcCtD
Oseltamivir—Hepatotoxicity—Temozolomide—malignant glioma	0.0124	0.0238	CcSEcCtD
Oseltamivir—Otitis media—Temozolomide—malignant glioma	0.0123	0.0236	CcSEcCtD
Oseltamivir—CES1—Irinotecan Pathway—BCHE—malignant glioma	0.0122	0.0629	CbGpPWpGaD
Oseltamivir—Accidental injury—Carmustine—malignant glioma	0.0112	0.0215	CcSEcCtD
Oseltamivir—NEU1—Sphingolipid metabolism—SPHK1—malignant glioma	0.0108	0.0556	CbGpPWpGaD
Oseltamivir—Herpes simplex—Temozolomide—malignant glioma	0.0104	0.02	CcSEcCtD
Oseltamivir—Hepatic enzyme increased—Temozolomide—malignant glioma	0.0102	0.0194	CcSEcCtD
Oseltamivir—Influenza like illness—Temozolomide—malignant glioma	0.00933	0.0179	CcSEcCtD
Oseltamivir—Diabetes mellitus—Carmustine—malignant glioma	0.0083	0.0159	CcSEcCtD
Oseltamivir—Swelling—Carmustine—malignant glioma	0.00818	0.0157	CcSEcCtD
Oseltamivir—NEU2—Sphingolipid metabolism—SPHK1—malignant glioma	0.00818	0.0422	CbGpPWpGaD
Oseltamivir—Ear pain—Temozolomide—malignant glioma	0.00817	0.0156	CcSEcCtD
Oseltamivir—Eye pain—Carmustine—malignant glioma	0.00799	0.0153	CcSEcCtD
Oseltamivir—Injury—Carmustine—malignant glioma	0.00785	0.015	CcSEcCtD
Oseltamivir—Hepatic failure—Temozolomide—malignant glioma	0.00776	0.0149	CcSEcCtD
Oseltamivir—Eye pain—Temozolomide—malignant glioma	0.00772	0.0148	CcSEcCtD
Oseltamivir—Nasal congestion—Temozolomide—malignant glioma	0.00765	0.0147	CcSEcCtD
Oseltamivir—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00722	0.0138	CcSEcCtD
Oseltamivir—CES1—central nervous system—malignant glioma	0.00721	0.0254	CbGeAlD
Oseltamivir—Face oedema—Carmustine—malignant glioma	0.00697	0.0133	CcSEcCtD
Oseltamivir—Face oedema—Temozolomide—malignant glioma	0.00673	0.0129	CcSEcCtD
Oseltamivir—Liver function test abnormal—Carmustine—malignant glioma	0.00666	0.0128	CcSEcCtD
Oseltamivir—CES1—Irinotecan Pathway—APC—malignant glioma	0.00662	0.0341	CbGpPWpGaD
Oseltamivir—ABCC4—Ectoderm Differentiation—CTNND2—malignant glioma	0.00655	0.0338	CbGpPWpGaD
Oseltamivir—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00628	0.012	CcSEcCtD
Oseltamivir—Bronchitis—Temozolomide—malignant glioma	0.0058	0.0111	CcSEcCtD
Oseltamivir—CES1—brain—malignant glioma	0.00573	0.0202	CbGeAlD
Oseltamivir—Upper respiratory tract infection—Temozolomide—malignant glioma	0.0056	0.0107	CcSEcCtD
Oseltamivir—Pneumonia—Carmustine—malignant glioma	0.00559	0.0107	CcSEcCtD
Oseltamivir—Pneumonia—Temozolomide—malignant glioma	0.0054	0.0103	CcSEcCtD
Oseltamivir—Infestation NOS—Temozolomide—malignant glioma	0.00537	0.0103	CcSEcCtD
Oseltamivir—Infestation—Temozolomide—malignant glioma	0.00537	0.0103	CcSEcCtD
Oseltamivir—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00533	0.0102	CcSEcCtD
Oseltamivir—Hepatobiliary disease—Temozolomide—malignant glioma	0.00508	0.00973	CcSEcCtD
Oseltamivir—Sinusitis—Temozolomide—malignant glioma	0.00504	0.00965	CcSEcCtD
Oseltamivir—Hallucination—Carmustine—malignant glioma	0.00497	0.00951	CcSEcCtD
Oseltamivir—ABCC4—central nervous system—malignant glioma	0.00485	0.0171	CbGeAlD
Oseltamivir—Hepatitis—Temozolomide—malignant glioma	0.00482	0.00923	CcSEcCtD
Oseltamivir—SLC22A8—central nervous system—malignant glioma	0.00482	0.017	CbGeAlD
Oseltamivir—Visual impairment—Carmustine—malignant glioma	0.00481	0.00921	CcSEcCtD
Oseltamivir—Hallucination—Temozolomide—malignant glioma	0.0048	0.00919	CcSEcCtD
Oseltamivir—Eye disorder—Carmustine—malignant glioma	0.00466	0.00893	CcSEcCtD
Oseltamivir—Visual impairment—Temozolomide—malignant glioma	0.00465	0.0089	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—FTH1—malignant glioma	0.00462	0.0238	CbGpPWpGaD
Oseltamivir—Erythema multiforme—Temozolomide—malignant glioma	0.00456	0.00873	CcSEcCtD
Oseltamivir—Eye disorder—Temozolomide—malignant glioma	0.00451	0.00863	CcSEcCtD
Oseltamivir—Cardiac disorder—Temozolomide—malignant glioma	0.00448	0.00857	CcSEcCtD
Oseltamivir—Arrhythmia—Carmustine—malignant glioma	0.00446	0.00853	CcSEcCtD
Oseltamivir—Mental disorder—Carmustine—malignant glioma	0.00437	0.00837	CcSEcCtD
Oseltamivir—Immune system disorder—Temozolomide—malignant glioma	0.00436	0.00834	CcSEcCtD
Oseltamivir—Mediastinal disorder—Temozolomide—malignant glioma	0.00435	0.00832	CcSEcCtD
Oseltamivir—Mental disorder—Temozolomide—malignant glioma	0.00423	0.00809	CcSEcCtD
Oseltamivir—Back pain—Carmustine—malignant glioma	0.0042	0.00804	CcSEcCtD
Oseltamivir—Back pain—Temozolomide—malignant glioma	0.00406	0.00777	CcSEcCtD
Oseltamivir—Anaemia—Carmustine—malignant glioma	0.00402	0.00769	CcSEcCtD
Oseltamivir—Agitation—Carmustine—malignant glioma	0.00399	0.00764	CcSEcCtD
Oseltamivir—Anaemia—Temozolomide—malignant glioma	0.00388	0.00743	CcSEcCtD
Oseltamivir—Agitation—Temozolomide—malignant glioma	0.00386	0.00739	CcSEcCtD
Oseltamivir—ABCC4—brain—malignant glioma	0.00385	0.0136	CbGeAlD
Oseltamivir—Angioedema—Temozolomide—malignant glioma	0.00384	0.00734	CcSEcCtD
Oseltamivir—SLC22A8—brain—malignant glioma	0.00382	0.0135	CbGeAlD
Oseltamivir—Vertigo—Temozolomide—malignant glioma	0.00377	0.00722	CcSEcCtD
Oseltamivir—Convulsion—Carmustine—malignant glioma	0.00376	0.00721	CcSEcCtD
Oseltamivir—Myalgia—Carmustine—malignant glioma	0.0037	0.00708	CcSEcCtD
Oseltamivir—Anxiety—Carmustine—malignant glioma	0.00369	0.00706	CcSEcCtD
Oseltamivir—Cough—Temozolomide—malignant glioma	0.00366	0.00701	CcSEcCtD
Oseltamivir—Convulsion—Temozolomide—malignant glioma	0.00364	0.00696	CcSEcCtD
Oseltamivir—Confusional state—Carmustine—malignant glioma	0.00358	0.00684	CcSEcCtD
Oseltamivir—Myalgia—Temozolomide—malignant glioma	0.00357	0.00684	CcSEcCtD
Oseltamivir—Arthralgia—Temozolomide—malignant glioma	0.00357	0.00684	CcSEcCtD
Oseltamivir—Anxiety—Temozolomide—malignant glioma	0.00356	0.00682	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00355	0.0068	CcSEcCtD
Oseltamivir—Infection—Carmustine—malignant glioma	0.00352	0.00674	CcSEcCtD
Oseltamivir—Thrombocytopenia—Carmustine—malignant glioma	0.00347	0.00665	CcSEcCtD
Oseltamivir—Confusional state—Temozolomide—malignant glioma	0.00346	0.00661	CcSEcCtD
Oseltamivir—Anaphylactic shock—Temozolomide—malignant glioma	0.00343	0.00656	CcSEcCtD
Oseltamivir—Infection—Temozolomide—malignant glioma	0.0034	0.00652	CcSEcCtD
Oseltamivir—Nervous system disorder—Temozolomide—malignant glioma	0.00336	0.00643	CcSEcCtD
Oseltamivir—Thrombocytopenia—Temozolomide—malignant glioma	0.00336	0.00642	CcSEcCtD
Oseltamivir—Skin disorder—Temozolomide—malignant glioma	0.00333	0.00637	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00323	0.00618	CcSEcCtD
Oseltamivir—Insomnia—Carmustine—malignant glioma	0.00321	0.00614	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00312	0.00598	CcSEcCtD
Oseltamivir—Insomnia—Temozolomide—malignant glioma	0.0031	0.00593	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Carmustine—malignant glioma	0.00306	0.00586	CcSEcCtD
Oseltamivir—Pain—Carmustine—malignant glioma	0.00303	0.0058	CcSEcCtD
Oseltamivir—Dyspepsia—Temozolomide—malignant glioma	0.00302	0.00577	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00296	0.00566	CcSEcCtD
Oseltamivir—Fatigue—Temozolomide—malignant glioma	0.00295	0.00566	CcSEcCtD
Oseltamivir—NEU1—Metabolism—RTEL1—malignant glioma	0.00295	0.0152	CbGpPWpGaD
Oseltamivir—Pain—Temozolomide—malignant glioma	0.00293	0.00561	CcSEcCtD
Oseltamivir—Feeling abnormal—Carmustine—malignant glioma	0.00292	0.00559	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Carmustine—malignant glioma	0.0029	0.00555	CcSEcCtD
Oseltamivir—Feeling abnormal—Temozolomide—malignant glioma	0.00282	0.00541	CcSEcCtD
Oseltamivir—Body temperature increased—Carmustine—malignant glioma	0.0028	0.00537	CcSEcCtD
Oseltamivir—Abdominal pain—Carmustine—malignant glioma	0.0028	0.00537	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Temozolomide—malignant glioma	0.0028	0.00536	CcSEcCtD
Oseltamivir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—malignant glioma	0.0028	0.0144	CbGpPWpGaD
Oseltamivir—Urticaria—Temozolomide—malignant glioma	0.00272	0.00521	CcSEcCtD
Oseltamivir—Abdominal pain—Temozolomide—malignant glioma	0.00271	0.00519	CcSEcCtD
Oseltamivir—Body temperature increased—Temozolomide—malignant glioma	0.00271	0.00519	CcSEcCtD
Oseltamivir—Hypersensitivity—Carmustine—malignant glioma	0.00261	0.005	CcSEcCtD
Oseltamivir—Asthenia—Carmustine—malignant glioma	0.00254	0.00487	CcSEcCtD
Oseltamivir—Hypersensitivity—Temozolomide—malignant glioma	0.00252	0.00483	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—FTH1—malignant glioma	0.00249	0.0129	CbGpPWpGaD
Oseltamivir—Asthenia—Temozolomide—malignant glioma	0.00246	0.00471	CcSEcCtD
Oseltamivir—Diarrhoea—Carmustine—malignant glioma	0.00243	0.00464	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—XBP1—malignant glioma	0.00238	0.0123	CbGpPWpGaD
Oseltamivir—Dizziness—Carmustine—malignant glioma	0.00235	0.00449	CcSEcCtD
Oseltamivir—Diarrhoea—Temozolomide—malignant glioma	0.00234	0.00449	CcSEcCtD
Oseltamivir—Dizziness—Temozolomide—malignant glioma	0.00227	0.00434	CcSEcCtD
Oseltamivir—Vomiting—Carmustine—malignant glioma	0.00225	0.00432	CcSEcCtD
Oseltamivir—NEU2—Metabolism—RTEL1—malignant glioma	0.00224	0.0115	CbGpPWpGaD
Oseltamivir—Rash—Carmustine—malignant glioma	0.00224	0.00428	CcSEcCtD
Oseltamivir—Dermatitis—Carmustine—malignant glioma	0.00223	0.00428	CcSEcCtD
Oseltamivir—Headache—Carmustine—malignant glioma	0.00222	0.00425	CcSEcCtD
Oseltamivir—Vomiting—Temozolomide—malignant glioma	0.00218	0.00417	CcSEcCtD
Oseltamivir—ABCC4—Ectoderm Differentiation—PIM1—malignant glioma	0.00216	0.0111	CbGpPWpGaD
Oseltamivir—Rash—Temozolomide—malignant glioma	0.00216	0.00414	CcSEcCtD
Oseltamivir—Dermatitis—Temozolomide—malignant glioma	0.00216	0.00413	CcSEcCtD
Oseltamivir—Headache—Temozolomide—malignant glioma	0.00215	0.00411	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.00211	0.0109	CbGpPWpGaD
Oseltamivir—Nausea—Carmustine—malignant glioma	0.00211	0.00403	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00204	0.0105	CbGpPWpGaD
Oseltamivir—Nausea—Temozolomide—malignant glioma	0.00204	0.0039	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—SLC5A5—malignant glioma	0.00185	0.00951	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—XBP1—malignant glioma	0.0018	0.00929	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—SPHK1—malignant glioma	0.00176	0.00909	CbGpPWpGaD
Oseltamivir—CES1—NRF2 pathway—SLC6A3—malignant glioma	0.00176	0.00906	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—COX8A—malignant glioma	0.0017	0.00874	CbGpPWpGaD
Oseltamivir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—malignant glioma	0.00165	0.0085	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.0016	0.00824	CbGpPWpGaD
Oseltamivir—SLC15A1—SLC-mediated transmembrane transport—APOD—malignant glioma	0.00157	0.00808	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00155	0.00798	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.00152	0.00781	CbGpPWpGaD
Oseltamivir—CES1—Fluoropyrimidine Activity—TP53—malignant glioma	0.00151	0.00777	CbGpPWpGaD
Oseltamivir—CES1—NRF2 pathway—GSTP1—malignant glioma	0.00149	0.00766	CbGpPWpGaD
Oseltamivir—NEU1—Post-translational protein modification—F2—malignant glioma	0.00146	0.0075	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—ASMT—malignant glioma	0.00144	0.00743	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—CDKN2A—malignant glioma	0.00143	0.00739	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—KNG1—malignant glioma	0.00143	0.00739	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.00141	0.00726	CbGpPWpGaD
Oseltamivir—SLC22A8—SLC-mediated transmembrane transport—APOD—malignant glioma	0.00139	0.00719	CbGpPWpGaD
Oseltamivir—ABCC4—Ectoderm Differentiation—SOX2—malignant glioma	0.00139	0.00718	CbGpPWpGaD
Oseltamivir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.00137	0.00708	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—KNG1—malignant glioma	0.00137	0.00704	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—BCAN—malignant glioma	0.00136	0.00699	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—SPHK1—malignant glioma	0.00134	0.00689	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—SOD1—malignant glioma	0.00133	0.00686	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—DOCK6—malignant glioma	0.00133	0.00686	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—COX8A—malignant glioma	0.00128	0.00662	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—SOD1—malignant glioma	0.00127	0.00654	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—BCHE—malignant glioma	0.00122	0.00628	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—FBXW7—malignant glioma	0.0012	0.00617	CbGpPWpGaD
Oseltamivir—CES1—NRF2 pathway—PDGFB—malignant glioma	0.00118	0.00606	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.00115	0.00592	CbGpPWpGaD
Oseltamivir—NEU2—Post-translational protein modification—F2—malignant glioma	0.0011	0.00569	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—IDH2—malignant glioma	0.00109	0.00563	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ASMT—malignant glioma	0.00109	0.00563	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.00107	0.0055	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.00103	0.00531	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CYP2B6—malignant glioma	0.00103	0.0053	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—BCAN—malignant glioma	0.00103	0.0053	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—PDGFB—malignant glioma	0.00103	0.00529	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00102	0.00528	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—SLC5A5—malignant glioma	0.000997	0.00514	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—PDGFB—malignant glioma	0.000978	0.00504	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—MYC—malignant glioma	0.000972	0.00501	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—SLC6A3—malignant glioma	0.000949	0.00489	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—IDH1—malignant glioma	0.000939	0.00484	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000936	0.00483	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—FN1—malignant glioma	0.000926	0.00478	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—BCHE—malignant glioma	0.000923	0.00476	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000911	0.00469	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—SPHK1—malignant glioma	0.000909	0.00469	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—FBXW7—malignant glioma	0.000908	0.00468	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CYP2C18—malignant glioma	0.000891	0.00459	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—FN1—malignant glioma	0.000882	0.00455	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—EGF—malignant glioma	0.000876	0.00452	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000873	0.0045	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.00084	0.00433	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—EGF—malignant glioma	0.000835	0.0043	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000833	0.00429	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—IDH2—malignant glioma	0.000828	0.00427	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000819	0.00422	CbGpPWpGaD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—TP53—malignant glioma	0.000813	0.00419	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—ATP1B2—malignant glioma	0.000806	0.00416	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—GSTP1—malignant glioma	0.000803	0.00414	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000799	0.00412	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000796	0.00411	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000781	0.00403	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYP2B6—malignant glioma	0.000778	0.00401	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000765	0.00394	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000738	0.00381	CbGpPWpGaD
Oseltamivir—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000737	0.0038	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000728	0.00375	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GSTT1—malignant glioma	0.00072	0.00371	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—IDH1—malignant glioma	0.000712	0.00367	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—APOD—malignant glioma	0.000708	0.00365	CbGpPWpGaD
Oseltamivir—SLC15A1—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000701	0.00361	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000698	0.0036	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—F2—malignant glioma	0.000691	0.00356	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—SPHK1—malignant glioma	0.000689	0.00355	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—APOD—malignant glioma	0.000679	0.0035	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PTGS1—malignant glioma	0.000675	0.00348	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYP2C18—malignant glioma	0.000675	0.00348	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000672	0.00347	CbGpPWpGaD
Oseltamivir—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000655	0.00338	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000636	0.00328	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—KNG1—malignant glioma	0.000636	0.00328	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—PDGFB—malignant glioma	0.000635	0.00327	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—BCHE—malignant glioma	0.000627	0.00323	CbGpPWpGaD
Oseltamivir—SLC22A8—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000624	0.00321	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—SLC5A5—malignant glioma	0.00062	0.0032	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—ANGPT2—malignant glioma	0.000594	0.00306	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—SOD1—malignant glioma	0.00059	0.00304	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000586	0.00302	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—MMP2—malignant glioma	0.000586	0.00302	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000581	0.00299	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.00058	0.00299	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.00056	0.00288	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTT1—malignant glioma	0.000546	0.00281	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PTK2—malignant glioma	0.000542	0.00279	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—VEGFA—malignant glioma	0.00053	0.00273	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—F2—malignant glioma	0.000523	0.0027	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—HIST1H3B—malignant glioma	0.000515	0.00265	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PTGS1—malignant glioma	0.000512	0.00264	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—MYB—malignant glioma	0.00051	0.00263	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.00051	0.00263	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000507	0.00261	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—malignant glioma	0.000505	0.0026	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GSTP1—malignant glioma	0.000499	0.00257	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—CXCL8—malignant glioma	0.000487	0.00251	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CAT—malignant glioma	0.000486	0.0025	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—BCHE—malignant glioma	0.000476	0.00245	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—SLC5A5—malignant glioma	0.00047	0.00242	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—NCOR1—malignant glioma	0.000459	0.00237	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PDGFB—malignant glioma	0.000455	0.00235	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000444	0.00229	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—MMP2—malignant glioma	0.000444	0.00229	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.00044	0.00227	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—FN1—malignant glioma	0.000411	0.00212	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—F2—malignant glioma	0.000411	0.00212	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000408	0.0021	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—H3F3A—malignant glioma	0.000398	0.00205	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	0.000393	0.00203	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—EGF—malignant glioma	0.000389	0.002	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000384	0.00198	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTP1—malignant glioma	0.000378	0.00195	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000374	0.00193	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CAV1—malignant glioma	0.000374	0.00193	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—CXCL8—malignant glioma	0.000369	0.0019	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CAT—malignant glioma	0.000368	0.0019	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000363	0.00187	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—AKT2—malignant glioma	0.00036	0.00185	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000357	0.00184	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000356	0.00184	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—NCOR1—malignant glioma	0.000348	0.00179	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000348	0.00179	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	0.000346	0.00178	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PIK3CG—malignant glioma	0.000341	0.00176	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000333	0.00172	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PPARG—malignant glioma	0.000329	0.0017	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—KNG1—malignant glioma	0.000328	0.00169	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—IFNA2—malignant glioma	0.000321	0.00165	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000319	0.00165	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000317	0.00163	CbGpPWpGaD
Oseltamivir—ABCC4—Ectoderm Differentiation—MYC—malignant glioma	0.000315	0.00163	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—RAF1—malignant glioma	0.000309	0.00159	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—SOD1—malignant glioma	0.000304	0.00157	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000304	0.00157	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	0.000301	0.00155	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PIK3CD—malignant glioma	0.000299	0.00154	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CAV1—malignant glioma	0.000283	0.00146	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PTK2—malignant glioma	0.000279	0.00144	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—IL2—malignant glioma	0.000277	0.00143	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000271	0.0014	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PIK3CB—malignant glioma	0.000261	0.00135	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PTGS2—malignant glioma	0.000259	0.00133	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CG—malignant glioma	0.000258	0.00133	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PPARG—malignant glioma	0.000249	0.00128	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	0.000235	0.00121	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PDGFB—malignant glioma	0.000235	0.00121	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CD—malignant glioma	0.000227	0.00117	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PTEN—malignant glioma	0.000226	0.00116	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—CAV1—malignant glioma	0.000222	0.00115	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—FN1—malignant glioma	0.000212	0.00109	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—F2—malignant glioma	0.000212	0.00109	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CG—malignant glioma	0.000203	0.00104	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—EGF—malignant glioma	0.0002	0.00103	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PTPN11—malignant glioma	0.000199	0.00103	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CB—malignant glioma	0.000198	0.00102	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PTGS2—malignant glioma	0.000196	0.00101	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—AKT2—malignant glioma	0.000185	0.000956	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	0.000184	0.000947	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CD—malignant glioma	0.000178	0.000919	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PTEN—malignant glioma	0.000171	0.000881	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000161	0.000832	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PIK3CA—malignant glioma	0.000159	0.00082	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—RAF1—malignant glioma	0.000159	0.00082	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CB—malignant glioma	0.000155	0.000801	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—AKT1—malignant glioma	0.00015	0.000773	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000144	0.00074	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—IL2—malignant glioma	0.000143	0.000735	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000138	0.00071	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—AKT1—malignant glioma	0.00013	0.00067	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—VEGFA—malignant glioma	0.000121	0.000625	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CA—malignant glioma	0.000121	0.000622	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—KRAS—malignant glioma	0.000103	0.000531	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—AKT1—malignant glioma	9.85e-05	0.000508	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CA—malignant glioma	9.47e-05	0.000488	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—TP53—malignant glioma	9.16e-05	0.000472	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—AKT1—malignant glioma	7.73e-05	0.000399	CbGpPWpGaD
